JAMES INVESTMENT RESEARCH INC - THRESHOLD PHARMACEUTICAL INC ownership

THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 50 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JAMES INVESTMENT RESEARCH INC ownership history of THRESHOLD PHARMACEUTICAL INC
ValueSharesWeighting
Q2 2017$32,000
-56.8%
82,626
-36.7%
0.00%
-50.0%
Q1 2017$74,000
+80.5%
130,623
+41.4%
0.00%
+100.0%
Q4 2016$41,000
+141.2%
92,353
+280.0%
0.00%
Q3 2016$17,00024,3030.00%
Other shareholders
THRESHOLD PHARMACEUTICAL INC shareholders Q1 2017
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,333,490$847,0000.43%
Cormorant Asset Management, LP 1,012,255$643,0000.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,583,160$1,641,0000.06%
Alpine Global Management, LLC 85,791$55,0000.02%
Rhenman & Partners Asset Management AB 201,537$128,0000.02%
FRANKLIN STREET ADVISORS INC /NC 70,000$44,0000.01%
LMR Partners LLP 80,123$51,0000.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,500,000$2,224,0000.01%
First Eagle Investment Management, LLC 3,199,433$2,033,0000.01%
OXFORD ASSET MANAGEMENT LLP 202,522$129,0000.00%
View complete list of THRESHOLD PHARMACEUTICAL INC shareholders